Variations in pharmacy-based transition-of-care activities in the United States: a national survey.

Autor: Kern KA; Kristine A. Kern, Pharm.D., is Clinical Pharmacy Specialist, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI. James S. Kalus, Pharm.D., BCPS (AQ-Infectious Diseases), is Senior Manager, Department of Pharmacy Services, Henry Ford Hospital, Detroit, MI. Colleen Bush, B.S., PRC, is Manager, Market Research; and David Chen, B.S.Pharm., M.B.A., is Director, Pharmacy Practice Sections and Section of Pharmacy Practice Managers, American Society of Health-System Pharmacists, Bethesda, MD. Edward G. Szandzik, B.S.Pharm., M.B.A., is Director, Department of Pharmacy Services; and Nadia Z. Haque, Pharm.D., M.H.S.A., BCPS, is Pharmacy Manager, Department of Pharmacy Services, Henry Ford Hospital., Kalus JS, Bush C, Chen D, Szandzik EG, Haque NZ

Publikováno v: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2014 Apr 15; Vol. 71 (8), pp. 648-56.

Emergence of methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of late-onset nosocomial pneumonia in intensive care patients in the USA.

Autor: Pasquale TR; Summa Health System, Akron City Hospital, 525 E. Market Street, Akron, OH 44304, USA. pasqualt@summahealth.org, Jabrocki B, Salstrom SJ, Wiemken TL, Peyrani P, Haque NZ, Scerpella EG, Ford KD, Zervos MJ, Ramirez JA, File TM Jr

Publikováno v: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2013 Jun; Vol. 17 (6), pp. e398-403. Date of Electronic Publication: 2013 Feb 01.

Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.

Autor: Cano EL; Division of Pulmonary and Critical Care Medicine, University of Miami Miller School of Medicine and Jackson Memorial Hospital, Miami, FL, USA., Haque NZ, Welch VL, Cely CM, Peyrani P, Scerpella EG, Ford KD, Zervos MJ, Ramirez JA, Kett DH

Publikováno v: Clinical therapeutics [Clin Ther] 2012 Jan; Vol. 34 (1), pp. 149-57.

Prediction of failure in vancomycin-treated methicillin-resistant Staphylococcus aureus bloodstream infection: a clinically useful risk stratification tool.

Autor: Moore CL; Division of Infectious Diseases, Henry Ford Hospital, 2799 West Grand Blvd., CFP 314, Detroit, MI 48202, USA. cmoore2@hfhs.org, Lu M, Cheema F, Osaki-Kiyan P, Perri MB, Donabedian S, Haque NZ, Zervos MJ

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2011 Oct; Vol. 55 (10), pp. 4581-8. Date of Electronic Publication: 2011 Aug 08.

Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia.

Autor: Haque NZ; Infectious Diseases, Wayne State University School of Medicine, Henry Ford Health System, Detroit, MI 48202, USA. mzervos1@hfhs.org, Zuniga LC, Peyrani P, Reyes K, Lamerato L, Moore CL, Patel S, Allen M, Peterson E, Wiemken T, Cano E, Mangino JE, Kett DH, Ramirez JA, Zervos MJ

Publikováno v: Chest [Chest] 2010 Dec; Vol. 138 (6), pp. 1356-62. Date of Electronic Publication: 2010 Jun 17.